| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
66,400 |
48,760 |
$9.53M |
| 99051 |
|
3,230 |
2,546 |
$42K |
| H2020 |
Therapeutic behavioral services, per diem |
148 |
88 |
$16K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
14,234 |
11,736 |
$437.88 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
37,028 |
28,419 |
$314.09 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,157 |
3,918 |
$62.66 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,422 |
1,747 |
$41.38 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
56 |
50 |
$1.50 |
| 90715 |
|
34 |
15 |
$0.66 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
249 |
213 |
$0.66 |
| 96127 |
|
328 |
243 |
$0.00 |
| 92551 |
|
335 |
261 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
641 |
567 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
816 |
586 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,197 |
932 |
$0.00 |
| 00000 |
|
722 |
439 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
72 |
42 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
78 |
65 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
198 |
158 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
25 |
25 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
80 |
51 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
57 |
51 |
$0.00 |
| 86580 |
|
22 |
16 |
$0.00 |
| 87807 |
|
39 |
34 |
$0.00 |
| 90461 |
|
956 |
691 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,492 |
1,133 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
37 |
16 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,569 |
1,127 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
80 |
51 |
$0.00 |
| 81002 |
|
577 |
446 |
$0.00 |
| 83655 |
|
362 |
237 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,650 |
1,166 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
45 |
36 |
$0.00 |
| 90734 |
|
51 |
31 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
67 |
26 |
$0.00 |
| 96160 |
|
597 |
509 |
$0.00 |
| 81025 |
|
57 |
55 |
$0.00 |
| 99173 |
|
197 |
166 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
57 |
34 |
$0.00 |
| 90649 |
|
60 |
41 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
19 |
12 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
20 |
18 |
$0.00 |
| 90633 |
|
18 |
12 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$0.00 |